Klas Bergenheim Selected Research

Therapeutics

4/2022	Cardiorenal disease in the United States: Future health care burden and potential impact of novel therapies.
4/2022	Modeling Chronic Kidney Disease in Type 2 Diabetes Mellitus: A Systematic Literature Review of Models, Data Sources, and Derivation Cohorts.
11/2020	Cost-effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health-economic analysis of DAPA-HF.
1/2016	The Health Economic Value of Changes in Glycaemic Control, Weight and Rates of Hypoglycaemia in Type 1 Diabetes Mellitus.
1/2015	Estimating Cost-Effectiveness in Type 2 Diabetes: The Impact of Treatment Guidelines and Therapy Duration.
2/2014	Cost effectiveness of adding dapagliflozin to insulin for the treatment of type 2 diabetes mellitus in the Netherlands.
3/2012	Cost effectiveness of saxagliptin and metformin versus sulfonylurea and metformin in the treatment of type 2 diabetes mellitus in Germany: a Cardiff diabetes model analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Klas Bergenheim Research Topics

Disease

7	Type 2 Diabetes Mellitus (MODY) 01/2021 - 03/2012
3	Diabetes Mellitus 04/2022 - 02/2014
2	Chronic Renal Insufficiency 12/2022 - 04/2022
2	Heart Failure 01/2021 - 11/2020
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 01/2016
1	Chronic Disease (Chronic Diseases) 04/2022
1	Weight Gain 01/2016
1	Diabetes Complications 02/2015

Drug/Important Bio-Agent (IBA)

6	dapagliflozinIBA 12/2022 - 02/2014
3	saxagliptin FDA Link 08/2017 - 03/2012
3	Metformin (Glucophage)FDA LinkGeneric 02/2015 - 03/2012
2	Insulin (Novolin)FDA Link 01/2020 - 02/2014
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2015
1	SodiumIBA 01/2020
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2020
1	Glipizide (Glucotrol)FDA LinkGeneric 07/2012

Therapy/Procedure

7	Therapeutics 04/2022 - 03/2012
1	Duration of Therapy 01/2015